Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 29;9(11):1252.
doi: 10.3390/vaccines9111252.

New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: A Systematic Review

Henry H L Wu  1   2 , Philip A Kalra  2   3 , Rajkumar Chinnadurai  2   3
Affiliations
Review

New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: A Systematic Review

Henry H L Wu et al. Vaccines (Basel). .

Abstract

Introduction: The introduction of COVID-19 vaccination programs has become an integral part of the major strategy to reduce COVID-19 numbers worldwide. New-onset and relapsed kidney histopathology have been reported following COVID-19 vaccination, sparking debate on whether there are causal associations. How these vaccines achieve an immune response to COVID-19 and the mechanism that this triggers kidney pathology remains unestablished. We describe the results of a systematic review for new-onset and relapsed kidney histopathology following COVID-19 vaccination.

Methods: A systematic literature search of published data up until 31 August 2021 was completed through the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guideline. Research articles reporting new onset or relapsed kidney histopathology in adult patients (>18 years) following COVID-19 vaccination were included for qualitative review. Only full-text articles published in the English language were selected for review.

Results: Forty-eight cases from thirty-six articles were included in the qualitative synthesis of this systematic review. Minimal change disease (19 cases) was the most frequent pathology observed, followed by IgA nephropathy (14 cases) and vasculitis (10 cases). Other cases include relapse of membranous nephropathy, acute rejection of kidney transplant, relapse of IgG4 nephritis, new-onset renal thrombotic microangiopathy, and scleroderma renal crisis following COVID-19 vaccination. There was no mortality reported in any of the included cases. Patients in all but one case largely recovered and did not require long-term renal replacement therapy.

Conclusion: This systematic review provides insight into the relationship between various kidney pathologies that may have followed COVID-19 vaccination. Despite these reported cases, the protective benefits offered by COVID-19 vaccination far outweigh its risks. It would be recommended to consider early biopsy to identify histopathology amongst patients presenting with symptoms relating to new-onset kidney disease following vaccination and to monitor symptoms for those with potential relapsed disease.

Keywords: COVID-19; COVID-19 vaccination; SARS-CoV-2; histopathology; kidney disease; new-onset; relapse; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
Figure 2
Figure 2
Summary of kidney pathologies and the type of COVID-19 vaccines administered.
See this image and copyright information in PMC

References

    1. Cheng Y., Luo R., Wang K., Zhang M., Wang Z., Dong L., Li J., Yao Y., Ge S., Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829–838. doi: 10.1016/j.kint.2020.03.005. - DOI - PMC - PubMed
    1. Ng J.H., Hirsch J.S., Wanchoo R., Sachdeva M., Sakhiya V., Hong S., Jhaveri K.D., Fishbane S., Abate M., Andrade H.P., et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98:1530–1539. doi: 10.1016/j.kint.2020.07.030. - DOI - PMC - PubMed
    1. Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int. Urol. Nephrol. 2020;52:1193–1194. doi: 10.1007/s11255-020-02451-9. - DOI - PMC - PubMed
    1. Windpessl M., Bruchfeld A., Anders H.-J., Kramer H., Waldman M., Renia L., Ng L.F.P., Xing Z., Kronbichler A. COVID-19 vaccines and kidney disease. Nat. Rev. Nephrol. 2021;17:291–293. doi: 10.1038/s41581-021-00406-6. - DOI - PMC - PubMed
    1. Reddy S., Chitturi C., Yee J. Vaccination in chronic kidney disease. Adv. Chronic Kidney Dis. 2019;26:72–78. doi: 10.1053/j.ackd.2018.10.002. - DOI - PubMed

LinkOut - more resources